Characterization of β2-glycoprotein I-dependent and -independent 'antiphospholipid' antibodies from lupus-prone NZW/BXSB F1 hybrid male mice

American Journal of Hematology

Volumn 56, Issue 2, 1997, Pages 86-92

  Thiagarajan, Perumal ^a   Le, Anhquyen ^a   Shapiro, Sandor S ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Anticardiolipin antibodies; Lupus; NZW BXSB mice

Indexed keywords

CARDIOLIPIN ANTIBODY; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; GLYCOPROTEIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CORONARY ARTERY DISEASE; LUPUS ERYTHEMATOSUS; MOUSE; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTOPENIA; ANIMAL; BLOOD CLOTTING; DRUG EFFECT; GENETIC PREDISPOSITION; GENETICS; HYBRIDIZATION; IMMUNOLOGY; LUPUS VULGARIS; MALE; METABOLISM; MOUSE STRAIN; PHYSIOLOGY;

ANIMALS; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BETA 2-GLYCOPROTEIN I; BLOOD COAGULATION; CARDIOLIPINS; GENETIC PREDISPOSITION TO DISEASE; GLYCOPROTEINS; HYBRIDIZATION, GENETIC; LUPUS; MALE; MICE; MICE, INBRED STRAINS;

EID: 0030610895     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199710)56:2<86::AID-AJH3>3.0.CO;2-X     Document Type: Article

References (33)

1. Shapiro SS, Thiagarajan P: Lupus anticoagulants. Prog Hemost Thromb 6:263-85, 1982.
2. Harris EN: The antiphospholipid syndrome. Diagnosis, management, and pathogonesis. Clin Rev Allergy Immunol 13:39-48, 1995.
3. McNeil HP, Krilis SA: Antiphospholipid antibodies. Aust NZ J Med 21:463-75, 1991.
4. Shapiro SS: The lupus anticoagulant/antiphospholipid syndrome. Annu Rev Med 47:533-553, 1996.
5. Exner T: Some recent developments with lupus anticoagulants. Blood Coag Fibrinol 5:281-289, 1994.
6. Triplett DA: Antiphospholipid-protein antibodies. Thromb Res 78:1-31, 1994.
7. Hang LM, Izui S, Dixon FJ: (NZW x BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease. J Exp Med 154:216-221, 1981.
8. Yoshida H, Fujiwara H, Fujiwara T, Ikehara S, Hamashima Y: Quantitative analysis of myocardial infarction in (NZW x BXSB) F1 hybrid mice and systemic lupus erythematosus and small coronary artery disease. Am J Pathol. 129:477-85, 1987.
9. Koike T: Anticardiolipin antibodies in NZW x BXSB F1 mice. Lupus 3:241-246, 1994.
10. Thiagarajan P, Perussia B, DeMarco L, Wells K, Trinchieri G: Membrane proteins on human megakaryocytes and platelets identified by monoclonal antibodies. Am J Hematol 14:255-269, 1983.
11. Clezardin P, McGregor JL, Manach M, Boukerche H, Dechavanne M: One-step procedure for the rapid isolation of mouse monoclonal antibodies. J Chromat 319:67-77, 1985.
12. Finlayson JS, Mushinski JF: Separation of subfractions of human beta-2-glycoprotein I. Biochim Biophys Acta 147:413-420, 1967.
13. McNeil HP, Chesterman CN, Krilis SA. Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroup with different phospholipid binding properties. Br J Haematol 73:506-513, 1989.
14. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth Young CG, Loizou S, Hughes GR: Anticardiolipin antibodies detection by radio-immunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2:1211-1214, 1983.
15. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci USA 87:4120-4124, 1990.
16. Galli M, Comfurius P, Maassen C, Hemker HC, deBaets MH, van-Breda Vriesman PJ, Barbui T, Zwaal RF, Bevers EM: Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma cofactor. Lancet 335:1544-1547, 1990.
17. Matsuura E, Igarasi Y, Fujimoto M, Ichikawa, Koike T: Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 336:822, 1990.
18. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RF: Lupus anticoagulant IgG's(LA) are not directed to phospholipids only but a complex of lipid bound prothrombin. Thromb Haemost 66:629-632, 1991.
19. 2-glycoprotein I in the expression of lupus anticoagulant activity. Blood 83:2878-2892, 1994.
20. Matsuda J, Saitoh N, Gohchi K, Gotoh M, Tsukamoto M: Anti-annexin V antibody in systemic lupus erythematosus patients. Am J Hematol 47:56-58, 1994.
21. Nakamura N, Shidara Y, Kawaguchi N, Azuma C, Mitsuda N, Onishi S, Yamaji K, Wada Y: Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cell: Involvement of annexin V. Biochem Biophys Res Commun 205:1488-1493, 1994.
22. Oosting JD, Derksen RHWM, Bobbink IW Hackeng TM, Bouma BN, deGroot PG: Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C and protein S: An explanation for their pathogenetic mechanism. Blood 81:2618-2625, 1993.
23. 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus 1:75-82, 1992.
24. Willems GM, Janssen MP, Pelsers MM, Comfurius P, Galli M, Zwaal RF, Bevers EM: Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes. Biochemistry 35:13833-13842, 1996.
25. Bocciolone L, Meroni P, Parazzini F, Tincani A, Radici E, Tarantini M, Rossi E, Bianchi C, Mezzanotte C, Angelo A: Antiphospholipid antibodies and risk of intrauterine late fetal. Acta Obstet Gynecol Scand 73:389-392, 1994.
26. Nimpf J, Bevers EM, Bomans PH, Till U, Wurm H, Kostner GM, Zwaal RF: Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein I. Biochim Biophys Acta 884:142-149, 1986.
27. Gharavi AE, Aron AL: Experimental models for antiphospholipid studies. Haemostasis 24:204-207, 1994.
28. Blank M, Tincani A, Shoenfeld Y: Induction of experimental antiphospholipid syndrome in naive mice. J Rheumatol 21:100-104, 1994.
29. Pierangeli SS, Barker JH, Stikovac D, Ackerman D, Anderson G, Barquinero J, Acland R, Harris EN: Effect of human IgG antiphospholipid antibodies on an in vivo thrombosis model in mice. Thromb Haemost 71:670-674, 1994.
30. Ordi Ros J, Selva OC, Monegal Ferran F, Monasterio Aspiri Y, Juste Sanchez C, Vilardell Tarres M: Prevalence, significance, and specificity of antibodies to phospholipid in Q fever. Clin Infect Dis 18:213-218, 1994.
31. Hashimoto Y, Kawamura M, Ichikawa K, Suzuki T, Sumida T, Yoshida S, Matsuura E, Ikehara S, Koike T: Anticardiolipin antibodies in NZW x BXSB F1 mice. A model of antiphospholipid antibody syndrome. J Immunol 149:1063-1068, 1992.
32. 2-glycoprotein I and cardiolipin. J Immunol 156:2631, 1996.
33. Olee T, Pierangeli SS, Handley HH, Le dt, Wei X, Lai CJ, En J, Novotny W, Harris EN, Woods VL, Chen PP: A monoclonal IgG cardiolipin antibody from a patient with anticardiolipin antibody from a patient with antiphospholipid antibody syndromes is thrombogenic in mice. Proc Natl Acad Sci USA 93:8606-8611, 1996.